Coca-Cola Hellenic Bottling Company
Coca-Cola Hellenic Bottling Company (CCHBC) is one of the largest bottling companies of The Coca-Cola Company. It operates in 28 countries, serving a population of approximately 600 million people. The company is headquartered in Zug, Switzerland, and is listed on the London Stock Exchange and the Athens Stock Exchange.
History[edit]
Coca-Cola Hellenic Bottling Company was formed in 2000 through the merger of the Hellenic Bottling Company and Coca-Cola Beverages. The company has since expanded its operations across Europe, Russia, and Nigeria.
Operations[edit]
CCHBC operates in three segments: Established markets, Developing markets, and Emerging markets. The company produces, sells, and distributes a wide range of non-alcoholic beverages, including carbonated soft drinks, juices, waters, sports drinks, and energy drinks.
Established Markets[edit]
The established markets include countries such as Greece, Italy, and Switzerland. These markets are characterized by high per capita consumption of Coca-Cola products.
Developing Markets[edit]
Developing markets include countries like Poland, Hungary, and the Czech Republic. These markets show potential for growth in beverage consumption.
Emerging Markets[edit]
Emerging markets include countries such as Russia, Nigeria, and Ukraine. These markets are experiencing rapid growth in demand for non-alcoholic beverages.
Sustainability Initiatives[edit]
Coca-Cola Hellenic Bottling Company is committed to sustainability and has implemented various initiatives to reduce its environmental impact. These include efforts to improve water efficiency, reduce carbon emissions, and promote recycling and waste management.
Community Engagement[edit]
CCHBC engages with local communities through various programs aimed at promoting health and wellness, supporting education, and fostering economic development.
See Also[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian